this post was submitted on 18 Jun 2026
79 points (100.0% liked)

Main, home of the dope ass bear.

16148 readers
201 users here now

THE MAIN RULE: ALL TEXT POSTS MUST CONTAIN "MAIN" OR BE ENTIRELY IMAGES (INLINE OR EMOJI)

(Temporary moratorium on main rule to encourage more posting on main. We reserve the right to arbitrarily enforce it whenever we wish and the right to strike this line and enforce mainposting with zero notification to the users because its funny)

A hexbear.net commainity. Main sure to subscribe to other communities as well. Your feed will become the Lion's Main!

Good comrades mainly sort posts by hot and comments by new!


gun-unity State-by-state guide on maintaining firearm ownership

guaido Domain guide on mutual aid and foodbank resources

smoker-on-the-balcony Tips for looking at financials of non-profits (How to donate amainly)

frothingfash Community-sourced megapost on the main media sources to radicalize libs and chuds with

just-a-theory An Amainzing Organizing Story

feminism Main Source for Feminism for Babies

data-revolutionary Maintaining OpSec / Data Spring Cleaning guide


ussr-cry Remain up to date on what time is it in Moscow

founded 5 years ago
MODERATORS
 

I cannot stress this enough: I live for the day these cruel bastards get gulaged. This shit is why I'm a leftist.

you are viewing a single comment's thread
view the rest of the comments
[โ€“] tithonis@hexbear.net 3 points 4 days ago (1 children)

I wrote in another comment to another post how imagining we know anything about why psychoactive substances do what they do is mere hubris, and it is. This argument is misguided, comrade. At best, it's utopian thinking. What is happening in practice is maximal suffering, with no benefit to public health (or positive outcomes on the individual level!) - how do we change society? Inventing a world where deprescription as it has been and is actually implemented ceases to exist somehow is utopian.

There's no contradiction between rejecting the chemical imbalance theory (which was originally a marketing scheme for Zoloft) and supporting the use of psych meds for those who benefit from using them.

I'm going to try and go a different direction here since other commenters have already said everything I'd like to say: psychiatry is extremely faddish, and deprescribing has been gaining some powerful friends the same way other interventions have in the past. As such it deserves to be treated with the same critical eye as any other trend in the field. Deprescribing is hot now because there is a way to profit from it. Any benefit or risk that accrues is incidental to the further commidification of disability and disabled people. Other people have written at length about this, if you're disabled you've probably seen it yourself: what drives trends in treatment is what treatment is available and who can monetize it. If it weren't profitable we wouldn't be seeing such a push for deprescription now, the same way we wouldn't have seen anxiety become depression become bipolar disorder (merely changing the name for the same underlying phenomena as different medications come on or off patent).

Benzodiazepines were considered largely benign until the manufacturer of Buspar decided to salt the literature to make space in the market for their "non-addictive anti-anxiety medication". MDD and GAD got redefined in the DSM as SSRIs emerged as alternate "serenics" or "anti-depressants". Social anxiety as a diagnosable nosological entity distinct from other anxiety disorders only exists because Paxil needed a new indication to extend its patent life. PMDD as a distinct nosological entity distinct from what had existed before but been coded as PMS or PMT (non-billable) is a thing because Prozac was going off patent and the manufacturer reformulated fluoxetine as a pink tablet to keep their rate of profit up. BPAD got fuzzed to include "has moods" as the market for "mood stabilizers" appeared around the turn of the century.

There have been no real advances in psychopharmacology since the introduction of the SSRIs and SGAs in the 1980s. We've been running on fumes and recombining old treatments for decades, creating prodrugs (Vyvanse/Elvanse) of 100 year old drugs, or turning ketamine into a single-enantiomer nasal spray. There's no money to be made in psychopharmacology now. Everything is generic, there's no marketing teams creating the pressure that there was 20, 30, 40 years ago.

The failure of nosology to account for human experience has nothing to do with whether somebody benefits from a medication or not. Force-tapering people is violence, but there's money in violence. There's metrics to create and hold prescribers to! We can further enclose and extract rent from the human experience and from human suffering in ways that don't differ from forced prescribing (or overprescribing, whatever) at all. Medication has no moral valence by itself but the choice to prescribe or deprescribe (and the necessity of a prescription to access certain medications in the first place) does.

And lastly, there is the whiff of disability-as-moral-failing and disability-as-contagion to this reasoning. Whether the cluster of experiences we call ADHD is nosologically coherent or not doesn't change the fact that there exist drugs that improve executive function and quality of life for certain people, and those people (myself among them) should have access to the medication they need without judgement or gatekeeping. "If we could treat the underlying causes then disability would cease to exist" is ahistorical. It's the same argument RFK is making, ultimately.

While I am (maybe a bit too) hyperbolic in my comment, I would never argue that we can eliminate mental illness, not even in a utopic world.

I also want to point out that I in no way whatsoever support deprescription in the sense of either force-tapering, removing access to medication or obstructing the path to recieve medical help.

When I have encountered ideas of deprescription previously, it has been connected to initiatives such as:

  • Informed consent about what the side effects may be, and the difficulties that some people experience when stopping SSRIs.
  • Better guidelines about how to stop or taper off SSRIs, along with regulation for companies to produce dosages small enough to taper off in a safe way.
  • A call for professionals to stop viewing medication as the "final stop" of treatment, but as another tool in the toolbox, where different options should be explored as well. All of which are aimed at helping people who don't find their medication helpful and are either unable to stop without the proper help or have been told that they shouldn't stop by their doctors.